Dr Gerhard Müller

Gerhard brings to Anavo proven expertise in small-molecule drug discovery and strong entrepreneurial skills supported by 25 years of practical and managerial experience in the European pharmaceutical, transatlantic biotech, and CRO industries. Throughout his career, Gerhard has worked on a wide range of different target classes in numerous disease areas. Gerhard’s expert knowledge in medicinal chemistry allowed him to establish novel design paradigms, proven by over 75 peer-reviewed publications. Prior to founding Anavo, he co-founded Gotham Therapeutics and held key positions at Mercachem, GPC Biotech, Axxima Pharmaceuticals, Glaxo, Bayer, and Organon. Gerhard received his PhD in organic chemistry from the Technical University of Munich, where he worked with Prof. Dr. Horst Kessler on anti-adhesive integrin antagonists.